- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03740854
The Effects of Two Different Ventilation Strategies on Lung Ventilation: An Ultrasonographic Evaluation.
February 26, 2019 updated by: Hacer Zeynep Turgut, Istanbul University
The Effects of Two Different Ventilation Strategies on Lung Ventilation in Patients Undergoing Robotic Radical Prostatectomy: Ultrasonographic Evaluation.
This study will be performed in robotic assisted laparoscopic radical prostatectomy patients in Cerrahpasa Medical Faculty Monoblock Operating Room.
Since robot-assisted laparoscopic radical prostatectomy is a surgical procedure which requires long-term mechanical ventilation, excessive trendelenburg position (30-45 °) and pneumoperitoneum; these interventions may lead to respiratory complications such as ventilation difficulty and aeration loss in patients.
Nowadays, lung ultrasonography has been used in anesthesia practice and intensive care units in order to determine lung aeration loss.
In this study, the investigators aimed to compare the possible aeration loss in lung parenchyma during pressure controlled ventilation and volume controlled ventilation which are frequently used in anesthesia practice in patients undergoing robotic radical prostatectomy.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
72
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Istanbul, Turkey
- Recruiting
- Medical Faculty of Cerrahpasa
-
Contact:
- Hacer Zeynep Turgut, MD
- Phone Number: +905057859922
- Email: drzturgut@gmail.com
-
Contact:
- Fatis Altintas, MD
- Phone Number: +905337785278
- Email: fatisaltintas@yahoo.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria: 18-75 age
- Patient who will be undergo robot assisted laparoscopic prostatectomy surgery
- Patient with ASA (American Society of Anesthesiologists) Score 1-3
Exclusion Criteria:
- Patients with ASA Score above 3
- Patients with obstructive (FEV1<%60) or restrictive pulmonary disease (FVC<%60)
- Patients with intrathoracic operation history
- Heavy smokers (>25 cigarettes/day)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Pressure Controlled Ventilation
Patients undergoing pressure controlled ventilation
|
Patients will be ventilated with a pressure level which supplies a tidal volume corresponding 8ml/kg, 12 breaths per minute, 1/2 inspiration/expiration ratio and %40 Fraction of Inspired Oxygen .
These ventilator settings can be changed in order to adjust end tidal carbon dioxide and oxygen saturation levels.
|
|
Active Comparator: Volume Controlled Ventilation
Patients undergoing volume controlled ventilation
|
Patients will be ventilated with a tidal volume which corresponds 8ml/kg, 12 breaths per minute, 1/2 inspirastion/expiration ratio and %40 Fraction of Inspired Oxygen .
These ventilator settings can be changed in order to adjust end tidal carbon dioxide and oxygen saturation levels.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The difference between LUS Scores at T5 in patients ventilated with VCV and PCV
Time Frame: (T5) 60 minutes after patients come to the recovery room.
|
Lung Ultrasonography will be applied to patients after surgery in the recovery room at T5. Two different groups' LUS scores will be calculated and compared.
|
(T5) 60 minutes after patients come to the recovery room.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The difference between LUS Scores at T2 in patients ventilated with VCV and PCV
Time Frame: (T2) 5 minutes after intubation
|
Lung Ultrasonography will be applied to patients after intubation.
Two different groups' LUS scores will be calculated and compared.
|
(T2) 5 minutes after intubation
|
|
The difference between LUS Scores at T3 in patients ventilated with VCV and PCV
Time Frame: (T3) 5 minutes after the surgical procedure is finished
|
Lung Ultrasonography will be applied to patients at Trendelenburg position after the surgical prosedure is finished.
Two different groups' LUS scores will be calculated and compared.
|
(T3) 5 minutes after the surgical procedure is finished
|
|
The difference between LUS Scores at T4 in patients ventilated with VCV and PCV
Time Frame: (T4) 5 minutes after taking the patient to supin position
|
Lung Ultrasonography will be applied to patients at supin position after the surgical prosedure is finished.
Two different groups' LUS scores will be calculated and compared.
|
(T4) 5 minutes after taking the patient to supin position
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Fatis Altintas, MD, Istanbul Unıversity-Cerrahpasa, Cerrahpasa Medical Faculty
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 4, 2018
Primary Completion (Anticipated)
November 1, 2019
Study Completion (Anticipated)
July 1, 2020
Study Registration Dates
First Submitted
November 12, 2018
First Submitted That Met QC Criteria
November 12, 2018
First Posted (Actual)
November 14, 2018
Study Record Updates
Last Update Posted (Actual)
February 27, 2019
Last Update Submitted That Met QC Criteria
February 26, 2019
Last Verified
February 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 68839
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prostate Cancer
-
Roswell Park Cancer InstituteRecruitingObesity | Overweight | Cancer Survivor | Prostate Adenocarcinoma | Stage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer | Stage IVA Prostate Cancer | Stage IVB Prostate Cancer | Stage A Prostate Cancer | Stage... and other conditionsUnited States
-
Cancer Institute and Hospital, Chinese Academy...RecruitingProstate Cancer Castration-resistant Prostate CancerChina
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Regeneron Pharmaceuticals; Prostate Cancer FoundationWithdrawnStage III Prostate Cancer | Stage IV Prostate Cancer | Stage IVA Prostate Cancer | Stage IVB Prostate Cancer | Stage IIIA Prostate Cancer | Stage IIIB Prostate Cancer | Stage IIIC Prostate Cancer
-
University of Southern CaliforniaNational Cancer Institute (NCI); SanofiTerminatedDiarrhea | Recurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Ohio State University Comprehensive Cancer CenterRiverside Methodist HospitalCompletedStage I Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
University of California, IrvineCompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Cancer Institute and Hospital, Chinese Academy...RecruitingProstate Cancer Castration-resistant Prostate CancerChina
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Jonsson Comprehensive Cancer CenterProgenics Pharmaceuticals, Inc.TerminatedRandomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer (PSMA-dRT)Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8 | Stage I Prostate...United States
-
Washington University School of MedicineThe Society of Nuclear Medicine and Molecular ImagingNot yet recruitingRecurrent Prostate Cancer | Prostate Cancer | Metastatic Prostate Cancer | Prostate Cancer Recurrent | Prostate Cancer MetastaticUnited States
Clinical Trials on Pressure Controlled Ventilation
-
Beni-Suef UniversityRecruitingVentilation Therapy; ComplicationsEgypt
-
Chung-Ang University Hosptial, Chung-Ang University...UnknownPostoperative Respiratory ComplicationKorea, Republic of
-
Ain Shams UniversityCompletedPostoperative Pulmonary DysfunctionEgypt
-
Yonsei UniversityCompletedGeneral AnesthesiaKorea, Republic of
-
Joseph D. TobiasCompleted
-
Centre Hospitalier Universitaire, AmiensCompletedCOPD Exacerbation | Weaning FailureFrance
-
Antalya Training and Research HospitalCompleted
-
Yonsei UniversityCompleted
-
Cairo UniversityCompleted
-
Technical University of MunichCompletedCardiopulmonary ResuscitationGermany